Skip to main content
Cannabis RadioCannabis Radio
ShowsDigital Marketing
Sign in

Loading...

Platform

  • All Shows
  • Search

Company

  • About
  • Contact

Legal

  • Privacy
  • Terms
  • Acceptable Use
  • DMCA Policy

© 2026 Cannabis Radio. All rights reserved.

Blunt Business

Adam Bierman, Former CEO Of MedMen Enterprises, On Blunt Business: The Biggest Takeaways As An Entrepreneur After Med Men's Decline

April 19, 202350 min

Adam Bierman, Former CEO Of MedMen Enterprises, On Blunt Business: The Biggest Takeaways As An Entrepreneur After Med Men's Decline

Blunt Business

0:00--:--
Adam Bierman is the co-founder and former CEO of MedMen Enterprises, the first American cannabis unicorn. During his decade at the company, it grew to five states, 32 retail stores, and 1500 employees. In 2019, MedMen lost 95% of its value and Adam chose to invest even more in the company despite advice to diversify. This led to lawsuits and MedMen essentially disappeared from the industry. Adam is now working with cannabis companies and investors to expand consumer access on a global scale. He was also responsible for setting the trend of dispensary design, with a layout similar to an Apple store. Adam, the founder of MedMen, a cannabis unicorn, had a ten-year run of building the company and brand. He left the company and gave up his board seat and voting rights. Since then, MedMen has gone through three CEOs and has not recovered. Adam's biggest takeaway from his experience is that even though he was the face of the company, it didn't matter as people expected that person to be a party animal. He believes that the same stories would have been told about the company and the person regardless of who it was.

Sponsored by The Buzz CRM

Brought to you by The Buzz CRM

The Buzz CRM proudly sponsors this show.

Enjoy this episode?

Subscribe to Blunt Business for new episodes.

More from Blunt Business

A Psychedelic and Cannabis Research Revolution On the Horizon?

A Psychedelic and Cannabis Research Revolution On the Horizon?

Blunt Business

This episode of Blunt Business explores a significant shift in federal drug policy following a new executive order aimed at accelerating research into psychedelics like LSD, psilocybin, and ibogaine for treating mental health disorders.

Apr 22, 202629 min
4/20 Fortune: Critics Say High-Stakes Holiday Losing Its Edge?

4/20 Fortune: Critics Say High-Stakes Holiday Losing Its Edge?

Blunt Business

As the legal landscape evolves, the traditional 4/20 retail boom is showing signs of cooling, with some markets seeing higher sales during the surrounding week than on the holiday itself due to aggressive discounting and operational…

Apr 15, 202624 min
Massachusetts Cannabis Market Overhaul and a Major MSO Files Bankruptcy

Massachusetts Cannabis Market Overhaul and a Major MSO Files Bankruptcy

Blunt Business

The cannabis landscape in Massachusetts and the broader U.S. market is undergoing a significant correction as regulators and major corporations grapple with the industry's economic realities.

Apr 8, 202625 min
Inside New York’s Five-Year Cannabis Chronicle

Inside New York’s Five-Year Cannabis Chronicle

Blunt Business

In this episode of The Blunt Business , the discussion dives deep into the complex landscape of the New York cannabis market as it hits its five-year legalization anniversary . While Governor Kathy Hochul lauds the state’s achievement of…

Apr 1, 202629 min
Loading comments...